Answer
Convulsions, depressed consciousness, abnormal behaviour, hallucinations and delirium have been reported during zanamivir (Relenza) use in influenza patients, mainly children and adolescents; convulsions and psychiatric symptoms also occur in influenza patients not taking Relenza.
Sources for this answer
- Relenza 5mg/dose inhalation powder.GlaxoSmithKline UK · emc · SmPC §4.8 Undesirable effects · Version 26Document updated
Sources checked